Vistin Pharma A Stock

Vistin Pharma A Dividend 2024

Vistin Pharma A Dividend

0.75 NOK

Vistin Pharma A Dividend yield

2.87 %

Ticker

VISTN.OL

ISIN

NO0010734122

WKN

A14TLR

How much dividend does Vistin Pharma A 2024 pay?

According to the latest status from November 2024, Vistin Pharma A paid a total of 0.75 NOK per share in dividends within the last 12 months. With the current Vistin Pharma A price of 26.1 NOK, this corresponds to a dividend yield of 2.87 %. A dividend is paid times per year.

2.87 % Dividend Yield=
0.75 NOK Dividend
26.1 NOK Stock Price

Historical Vistin Pharma A Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend
12/6/20240.5
7/5/20240.5
2/23/20240.75
6/20/20220.75
6/21/20210.5
6/20/20201
12/3/20177
6/26/20171
6/25/20160.6
1

Vistin Pharma A dividend history and estimates

In 2023, Vistin Pharma A paid a dividend amounting to 0 NOK. Dividend means that Vistin Pharma A distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Vistin Pharma A provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Vistin Pharma A’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Vistin Pharma A's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Vistin Pharma A Dividend History

DateVistin Pharma A Dividend
20220.75 undefined
20210.5 undefined
20201 undefined
20177.93 undefined
20160.59 undefined

Is the Vistin Pharma A Dividend Safe?

Vistin Pharma A has been increasing the dividend for 2 years.

Over the past 9 years, Vistin Pharma A has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Vistin Pharma A dividend payout ratio

In 2023, Vistin Pharma A had a payout ratio of 114.33%. The payout ratio indicates the percentage of the company's profits that Vistin Pharma A distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Vistin Pharma A represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Vistin Pharma A could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Vistin Pharma A's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Vistin Pharma A Payout Ratio History

DateVistin Pharma A Payout ratio
2023114.33 %
2022-705.22 %
202189.16 %
2020-45.74 %
2019133.86 %
2018119.96 %
2017192.45 %
201678.25 %
2015119.96 %

Dividend Details

Understanding Vistin Pharma A's Dividend Distributions

Vistin Pharma A’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Vistin Pharma A's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Vistin Pharma A's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Vistin Pharma A’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Vistin Pharma A Aktienanalyse

What does Vistin Pharma A do?

Vistin Pharma ASA is a Norwegian company specializing in the production and sale of chemical products. The company was founded in 1997 and is headquartered in Oslo. History: The company started as a chemical products manufacturer but quickly began focusing on the production of pharmaceutical products and active ingredients in the early 2000s. In 2016, the subsidiary Vistin Pharma Production AS was established, specializing in the production of active ingredients for the chemical industry. Business model: Vistin Pharma is a niche provider of specialized chemical and pharmaceutical products. The company focuses on producing high-quality products for selected markets and industries where it has a competitive position. The business model is based on a combination of advanced research and development, state-of-the-art production facilities, and a comprehensive network of sales partners and distributors. Different divisions: Vistin Pharma's business activities mainly focus on two main divisions: Pharmaceuticals and Industrial Active Ingredients. The Pharmaceuticals division includes the production and sale of active ingredients for the production of human and animal health medications. The products include Metformin, an active ingredient for treating diabetes, as well as Methotrexate tablets for cancer treatment. The Industrial Active Ingredients division produces active ingredients for various industries, including cosmetics, food, and energy sectors. Products: One of Vistin Pharma's best-known products is Metformin, an orally administered medication for treating type 2 diabetes. Metformin helps control and lower blood sugar levels by preventing the liver from producing too much glucose and improving the body's sensitivity to insulin. Vistin Pharma's Methotrexate tablets are used to treat a variety of cancers, including breast cancer, lung cancer, and leukemia. Overall, Vistin Pharma offers a wide range of chemical and pharmaceutical products suitable for various applications. The company places great emphasis on quality and sustainability and strives to offer its customers high-quality and environmentally friendly products and services. Conclusion: Vistin Pharma is an innovative Norwegian pharmaceutical and chemical company that has been focused on producing and selling high-quality products since its inception. With a wide range of chemical and pharmaceutical products and a strong focus on research and development, product quality, and sustainability, Vistin Pharma is well-positioned to continue growing and establish itself as a leading provider in its core markets. The output translation is: Vistin Pharma ASA is a Norwegian company specializing in the production and sale of chemical and pharmaceutical products. It was founded in 1997 and is headquartered in Oslo. The company has expanded from being a chemical products manufacturer to producing pharmaceutical products and active ingredients. It operates through two main divisions: Pharmaceuticals and Industrial Active Ingredients. Vistin Pharma's products include Metformin for treating diabetes and Methotrexate tablets for cancer treatment. The company focuses on providing high-quality and environmentally friendly products and services. With its strong emphasis on research and development, product quality, and sustainability, Vistin Pharma aims to become a leading player in its core markets. Vistin Pharma A is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Vistin Pharma A stock

How much dividend does Vistin Pharma A pay?

Over the past 12 months, Vistin Pharma A paid a dividend of 0.75 NOK . This corresponds to a dividend yield of about 2.87 %. For the coming 12 months, Vistin Pharma A is expected to pay a dividend of 0.75 NOK.

What is the dividend yield of Vistin Pharma A?

The current dividend yield of Vistin Pharma A is 2.87 %.

When does Vistin Pharma A pay dividends?

Vistin Pharma A pays a quarterly dividend. This is distributed in the months of June, February, July, December.

How secure is the dividend of Vistin Pharma A?

Vistin Pharma A paid dividends every year for the past 0 years.

What is the dividend of Vistin Pharma A?

For the upcoming 12 months, dividends amounting to 0.75 NOK are expected. This corresponds to a dividend yield of 2.87 %.

In which sector is Vistin Pharma A located?

Vistin Pharma A is assigned to the 'Health' sector.

Wann musste ich die Aktien von Vistin Pharma A kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Vistin Pharma A from 11/19/2024 amounting to 0.5 NOK, you needed to have the stock in your portfolio before the ex-date on 11/6/2024.

When did Vistin Pharma A pay the last dividend?

The last dividend was paid out on 11/19/2024.

What was the dividend of Vistin Pharma A in the year 2023?

In the year 2023, Vistin Pharma A distributed 0.5 NOK as dividends.

In which currency does Vistin Pharma A pay out the dividend?

The dividends of Vistin Pharma A are distributed in NOK.

Andere Kennzahlen von Vistin Pharma A

Our stock analysis for Vistin Pharma A Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vistin Pharma A Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.